Menu

Prosthetic Retinas Help Blind Mice See

Artificial photoreceptors made of nanowires help restore blind animals’ sensitivity to light.

Mar 6, 2018
Ashley Yeager

Human rod photoreceptors (green) and cone photoreceptors and horizontal cells (red).FLICKR, NATIONAL EYE INSTITUTETitanium dioxide nanowires coated in gold nanoparticles have restored blind mice’s ability to detect changes in light. The prosthetic, described today (March 6) in Nature Communications, could provide a step toward developing similar devices to restore vision in people with macular degeneration and other eye diseases.

In the study, chemist Gengfeng Zheng of Fudan University in Shanghai and his colleagues replaced the rod and cone cells in blind mice’s eyes with prosthetic retinas made of arrays of the gold-coated titanium dioxide nanowires. When the researchers shone ultraviolet, blue, and green light into the devices, the mice’s pupils constricted, a change the scientists did not see when they shone light into the eyes of the mice before the prosthetic was implanted. The prosthetic absorbs light, which generates photovoltage and triggers electrical activity in neurons nearby, restoring the mice’s sensitivity to light, the authors explain in the paper.

The prosthetic doesn’t currently allow for full color vision, the researchers note, so they are working on incorporating nanowires that are sensitive to different wavelengths of light, perhaps making it possible for mice, and one day humans, with the implant to differentiate the colors of the rainbow.

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.